Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jun;8(3):996-1000.
doi: 10.21037/tcr.2019.05.13.

Successful treatment of giant mesenteric fibromatosis with surgery and tamoxifen: case report

Affiliations
Case Reports

Successful treatment of giant mesenteric fibromatosis with surgery and tamoxifen: case report

Zhixiang Jin et al. Transl Cancer Res. 2019 Jun.

Abstract

A 65-year-old man underwent excision of a giant mesenteric fibromatosis (MF) via combined splenectomy and partial transverse colectomy. Pathological examination confirmed the presence of MF, whereas genetic testing indicated that the tumor was sensitive to tamoxifen. Over a 1-year follow-up, no symptoms of abdominal discomfort or recurrence was noted.

Keywords: Aggressive fibromatosis (AF); desmoid-type fibromatosis; mesenteric fibromatosis (MF); tamoxifen.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tcr.2019.05.13). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Computed tomography (CT) showed a 16 cm × 12 cm space-occupying lesion in the left upper abdomen.
Figure 2
Figure 2
The tumor was completely resected via splenectomy and segmental transverse colectomy.
Figure 3
Figure 3
The results of HE staining and immunohistochemistry. (A,B) HE staining showed the arrangement of abundant cells in a fascicle (A) or whirlpool (B) manner. (C,D,E) Immunohistochemistry indicated vimentin(+) (C), SMA(+) (D), and β-catenin(+) (E). Magnification, ×100.

References

    1. Efthimiopoulos GA, Chatzifotiou D, Drogouti M, et al. Primary asymptomatic desmoid tumor of the mesentery. Am J Case Rep 2015;16:160-3. 10.12659/AJCR.892521 - DOI - PMC - PubMed
    1. Wronski M, Ziarkiewicz-Wroblewska B, Slodkowski M, et al. Mesenteric fibromatosis with intestinal involvement mimicking a gastrointestinal stromal tumour. Radiol Oncol 2011;45:59-63. 10.2478/v10019-010-0051-7 - DOI - PMC - PubMed
    1. Stout AP. Juvenile fibromatoses. Cancer 1954;7:953-78. 10.1002/1097-0142(195409)7:5<953::AID-CNCR2820070520>3.0.CO;2-W - DOI - PubMed
    1. van Broekhoven DL, Grünhagen DJ, den Bakker MA, et al. Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: a population-based study. Ann Surg Oncol 2015;22:2817-23. 10.1245/s10434-015-4632-y - DOI - PMC - PubMed
    1. Bn A, Cd JK, Ps S, et al. Giant aggressive mesenteric fibromatosis- a case report. J Clin Diagn Res 2015;9:PD07-8. - PMC - PubMed

Publication types